Literature DB >> 24518554

Reply to Shin and Bayry on "An age-related decline of CD62L and vaccine response: a role of microRNA 92a?".

Thomas Vorup-Jensen1, Carina Rosenberg1, Eskild Petersen2.   

Abstract

Aging of the human body affects the immune system by a decline in the ability to raise a response to challenges such as microbial infections or vaccinations. In the very elderly, the decline in such functions appears to relate to a reduced expression of certain co-stimulatory molecules expressed by T lymphocytes. More recently, attention has been drawn to the adhesion molecule CD62L, where differences in expression and function of this molecule between younger and older individuals are suspected to be a part of immunosenescence in the elderly.

Entities:  

Keywords:  CD62L; HBV; adhesion molecule; age; glycosylation

Mesh:

Substances:

Year:  2014        PMID: 24518554      PMCID: PMC4896509          DOI: 10.4161/hv.27843

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  5 in total

1.  CD50 and CD62L adhesion receptor expression on naive (CD45RA+) and memory (CD45RO+) T lymphocytes in the elderly.

Authors:  M De Martinis; M Modesti; V F Profeta; M Tullio; M F Loreto; L Ginaldi; D Quaglino
Journal:  Pathobiology       Date:  2000       Impact factor: 4.342

Review 2.  CD28(-) T cells: their role in the age-associated decline of immune function.

Authors:  Nan-Ping Weng; Arne N Akbar; Jorg Goronzy
Journal:  Trends Immunol       Date:  2009-06-18       Impact factor: 16.687

3.  Age is an important determinant in humoral and T cell responses to immunization with hepatitis B surface antigen.

Authors:  Carina Rosenberg; Nicolai V Bovin; Lone Valentin Bram; Eigil Flyvbjerg; Mogens Erlandsen; Thomas Vorup-Jensen; Eskild Petersen
Journal:  Hum Vaccin Immunother       Date:  2013-04-09       Impact factor: 3.452

4.  Age-related decrease of miRNA-92a levels in human CD8+ T-cells correlates with a reduction of naïve T lymphocytes.

Authors:  Michiyo Ohyashiki; Junko H Ohyashiki; Ayako Hirota; Chiaki Kobayashi; Kazuma Ohyashiki
Journal:  Immun Ageing       Date:  2011-11-15       Impact factor: 6.400

Review 5.  Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?

Authors:  Babak Jalilian; Stig Hill Christiansen; Halldór Bjarki Einarsson; Mehdi Rasoli Pirozyan; Eskild Petersen; Thomas Vorup-Jensen
Journal:  Mol Cell Ther       Date:  2013-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.